Profil
Howard J.
Franklin worked as Chief Medical Officer at Salix Pharmaceuticals Ltd. from 2018 to 2022.
Also worked as Chief Medical Officer at Finch Therapeutics Group, Inc. Worked as Senior Vice President-Medical at Assertio Holdings, Inc. from 2023 to 2026.
Education includes a doctorate from Drexel University College of Medicine, an undergraduate degree from Lehigh University, and an MBA from LaSalle University.
Ehemalige bekannte Positionen von Howard Franklin
| Unternehmen | Position | Ende |
|---|---|---|
| ASSERTIO HOLDINGS | Technik-/Wissenschafts-/F&E-Leiter | 16.06.2026 |
| SALIX PHARMACEUTICALS, LTD. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 |
| FINCH THERAPEUTICS GROUP, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Howard Franklin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Salix Pharmaceuticals Ltd.
Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops prescription drugs | Health Technology |
LaSalle University
LaSalle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc. Medical/Nursing ServicesHealth Services Provides microbial therapy services | Health Services |
Assertio Holdings, Inc.
Assertio Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
















